Christoph Herrmann-Lingen Selected Research

4-amino-4'-hydroxylaminodiphenylsulfone (HADS)

12/2021	Influence of baseline parameters on one-year physical, mental, and health-related quality of life in patients with heart failure and preserved ejection fraction.
1/2020	Diagnostic evaluation of the hospital depression scale (HADS) and the Beck depression inventory II (BDI-II) in adults with congenital heart disease using a structured clinical interview: Impact of depression severity.
1/2019	Somatic and sociodemographic predictors of depression outcome among depressed patients with coronary artery disease - a secondary analysis of the SPIRR-CAD study.
1/2018	Prevalence of mental disorders among depressed coronary patients with and without Type D personality. Results of the multi-center SPIRR-CAD trial.
6/2014	Screening for mental disorders in heart failure patients using computer-adaptive tests.
3/2012	[Psychological distress of breast cancer patients: screening and patients' request for psycho-oncological care as indicators of health-related quality of life].
11/2007	Depressive symptoms predict recurrence of atrial fibrillation after cardioversion.
10/2007	Psychological distress in primary care patients with heart failure: a longitudinal study.
11/2004	Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis.
12/2003	Detecting panic disorder in medical and psychosomatic outpatients: comparative validation of the Hospital Anxiety and Depression Scale, the Patient Health Questionnaire, a screening question, and physicians' diagnosis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christoph Herrmann-Lingen Research Topics

Disease

26	Heart Failure 01/2022 - 07/2003
7	Coronary Artery Disease (Coronary Atherosclerosis) 02/2022 - 02/2008
6	Atrial Fibrillation 01/2022 - 11/2007
5	Coronary Disease (Coronary Heart Disease) 01/2021 - 01/2015
4	Diastolic Heart Failure 12/2021 - 08/2010
4	Cardiac Arrhythmias (Arrythmia) 01/2018 - 08/2004
3	Pain (Aches) 02/2022 - 01/2002
3	Cardiovascular Diseases (Cardiovascular Disease) 12/2021 - 05/2010
3	Fatigue 12/2021 - 05/2010
3	Disease Progression 01/2020 - 12/2015
3	Hypertension (High Blood Pressure) 01/2019 - 01/2015
3	Inflammation (Inflammations) 02/2017 - 02/2015
2	Neoplasms (Cancer) 06/2022 - 12/2009
2	Hypesthesia (Numbness) 02/2022 - 07/2020
2	Stroke (Strokes) 01/2021 - 01/2015
2	Chronic Disease (Chronic Diseases) 12/2020 - 12/2016
2	Major Depressive Disorder (Major Depressive Disorders) 01/2020 - 11/2004
2	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2019 - 02/2017
2	Mental Disorders (Mental Disorder) 01/2018 - 03/2012
2	Left Ventricular Dysfunction 04/2010 - 02/2008
2	Panic Disorder (Panic Attack) 12/2003 - 07/2003
1	Lung Neoplasms (Lung Cancer) 06/2022
1	Occupational Stress 02/2022
1	Muscle Cramp (Cramp) 02/2022
1	Wounds and Injuries (Trauma) 01/2022
1	Delirium 10/2021
1	COVID-19 10/2021
1	Headache (Headaches) 04/2021
1	Iron Deficiencies 01/2021
1	Congenital Heart Defects (Congenital Heart Defect) 01/2020
1	Heart Diseases (Heart Disease) 01/2019
1	Myocardial Infarction 01/2019
1	Hyperuricemia 01/2019
1	Peripheral Arterial Occlusive Disease 1 01/2018
1	Asthma (Bronchial Asthma) 01/2018
1	Drug Hypersensitivity (Drug Allergy) 01/2018
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2018
1	Renal Insufficiency (Renal Failure) 01/2018
1	Atherosclerosis 01/2018
1	Obesity 02/2017
1	Hypotension (Low Blood Pressure) 02/2017

Drug/Important Bio-Agent (IBA)

11	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 12/2021 - 01/2002
7	pro-brain natriuretic peptide (1-76)IBA 01/2022 - 02/2008
7	Spironolactone (Aldactone)FDA LinkGeneric 10/2021 - 08/2010
7	Natriuretic PeptidesIBA 01/2019 - 07/2003
5	AldosteroneIBA 12/2021 - 08/2010
4	Biomarkers (Surrogate Marker)IBA 10/2021 - 12/2010
4	Bisoprolol (Concor)FDA LinkGeneric 06/2013 - 06/2011
3	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022 - 01/2019
3	Galectin 3 (LGALS3)IBA 01/2021 - 02/2015
3	Carvedilol (Coreg)FDA LinkGeneric 06/2013 - 06/2011
2	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2022 - 03/2016
2	Biological ProductsIBA 12/2021 - 10/2018
2	Uric Acid (Urate)IBA 04/2019 - 01/2019
2	Antihypertensive Agents (Antihypertensives)IBA 01/2019 - 01/2018
2	proAVP hormoneIBA 01/2019 - 02/2017
2	Anti-Anxiety Agents (Anxiolytics)IBA 01/2019 - 07/2003
2	Triglycerides (Triacylglycerol)IBA 01/2019 - 01/2019
2	Vitamin D FDA LinkGeneric 02/2017 - 12/2016
2	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 02/2013 - 08/2010
1	Calcitriol (Calcijex)FDA LinkGeneric 02/2022
1	xylometazoline (stas)IBA 01/2022
1	CoagulantsIBA 12/2021
1	MagnesiumIBA 04/2021
1	Contraceptive Agents (Contraceptives)IBA 04/2021
1	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2021
1	HematinicsIBA 01/2021
1	IronIBA 01/2021
1	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 08/2020
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 08/2020
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 07/2020
1	saccharide-binding proteinsIBA 01/2020
1	hydroxide ionIBA 04/2019
1	CholesterolIBA 01/2019
1	Arginine Vasopressin (Argipressin)IBA 01/2019
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2019
1	Analgesics (Analgesic Drugs)IBA 01/2019
1	LipidsIBA 01/2019
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2019
1	LDL CholesterolIBA 01/2019
1	Thyroid HormonesIBA 01/2019
1	Cholinergic Antagonists (Anticholinergics)IBA 01/2019
1	ORALIT (ORS)IBA 01/2018
1	Interleukin-6 (Interleukin 6)IBA 02/2017
1	Interleukin-10 (Interleukin 10)IBA 02/2017
1	LeptinIBA 02/2017
1	AdiponectinIBA 02/2017
1	AdipokinesIBA 02/2017

Therapy/Procedure

8	Therapeutics 06/2022 - 01/2009
3	Secondary Prevention 01/2021 - 01/2020
2	Electric Countershock (Cardioversion) 02/2022 - 11/2007
2	Percutaneous Coronary Intervention 01/2022 - 01/2015
2	Heart Transplantation (Grafting, Heart) 10/2021 - 01/2019
2	Resuscitation 01/2019 - 08/2004
2	Defibrillators (Defibrillator) 11/2007 - 08/2004
1	Drug Therapy (Chemotherapy) 06/2022
1	Activities of Daily Living (ADL) 01/2021
1	Patient Readmission 10/2019
1	Cardiac Rehabilitation 01/2019
1	Heart-Assist Devices 01/2019